Literature DB >> 33718428

Usefulness of Intraoperative Neurophysiological Monitoring During the Clipping of Unruptured Intracranial Aneurysm: Diagnostic Efficacy and Detailed Protocol.

Dougho Park1, Byung Hee Kim1, Sang-Eok Lee1, Eunhwan Jeong2, Kwansang Cho3, Ji Kang Park4, Yeon-Ju Choi5, Suntak Jin5, Daeyoung Hong5, Mun-Chul Kim5.   

Abstract

Background: Intraoperative neurophysiological monitoring (IONM) has been widely applied in brain vascular surgeries to reduce postoperative neurologic deficit (PND). This study aimed to investigate the effect of IONM during clipping of unruptured intracranial aneurysms (UIAs).
Methods: Between January 2013 and August 2020, we enrolled 193 patients with 202 UIAs in the N group (clipping without IONM) and 319 patients with 343 UIAs in the M group (clipping with IONM). Patients in the M group were intraoperatively monitored for motor evoked potentials (MEPs) and somatosensory evoked potentials (SSEPs). Irreversible evoked potential (EP) change was defined as EP deterioration that did not recover until surgery completion. Sustained PND was defined as neurological symptoms lasting for more than one postoperative month.
Results: Ten (3.1%) and 13 (6.7%) in the M and N groups, respectively, presented with PND. Compared with the N group, the M group had significantly lower occurrence rates of sustained PND [odds ratio (OR) = 0.36, 95% confidence interval (CI) = 0.13-0.98, p = 0.04], ischemic complications (OR = 0.39, 95% CI = 0.15-0.98, p = 0.04), and radiologic complications (OR = 0.40, 95% CI = 0.19-0.82, p = 0.01). Temporary clipping was an independent risk factor for ischemic complications (ICs) in the total patient group (OR = 6.18, 95% CI = 1.75-21.83, p = 0.005), but not in the M group (OR = 5.53, 95% CI = 0.76-41.92, p = 0.09). Regarding PND prediction, considering any EP changes (MEP and/or SSEP) showed the best diagnostic efficiency with a sensitivity of 0.900, specificity of 0.940, positive predictive value of 0.321, negative predictive value (NPV) of 0.997, and a negative likelihood ratio (LR) of 0.11.
Conclusion: IONM application during UIA clipping can reduce PND and radiological complications. The diagnostic effectiveness of IONM, specifically the NPV and LR negative values, was optimal upon consideration of changes in any EP modality.
Copyright © 2021 Park, Kim, Lee, Jeong, Cho, Park, Choi, Jin, Hong and Kim.

Entities:  

Keywords:  intracranial aneurysms; intraoperative neurophysiological monitoring; motor evoked potential; postoperative complication; somatosensory evoked potential

Year:  2021        PMID: 33718428      PMCID: PMC7952634          DOI: 10.3389/fsurg.2021.631053

Source DB:  PubMed          Journal:  Front Surg        ISSN: 2296-875X


  41 in total

1.  Sensitivity and Specificity of Intraoperative Neuromonitoring for Identifying Safety and Duration of Temporary Aneurysm Clipping Based on Vascular Territory, a Multimodal Strategy.

Authors:  Brittany Staarmann; Kelly O'Neal; Mark Magner; Mario Zuccarello
Journal:  World Neurosurg       Date:  2017-01-13       Impact factor: 2.104

2.  Intraoperative neurophysiological monitoring in aneurysm clipping: Does it make a difference? A systematic review and meta-analysis.

Authors:  Davide Nasi; Stefano Meletti; Vincenzo Tramontano; Giacomo Pavesi
Journal:  Clin Neurol Neurosurg       Date:  2020-05-29       Impact factor: 1.876

3.  Incidental findings on brain MRI in the general population.

Authors:  Meike W Vernooij; M Arfan Ikram; Hervé L Tanghe; Arnaud J P E Vincent; Albert Hofman; Gabriel P Krestin; Wiro J Niessen; Monique M B Breteler; Aad van der Lugt
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

4.  Multimodal Intraoperative Neuromonitoring in Aneurysm Surgery.

Authors:  Giovanni Grasso; Alessandro Landi; Concetta Alafaci
Journal:  World Neurosurg       Date:  2017-03-03       Impact factor: 2.104

5.  Introduction of intraoperative neuromonitoring does not necessarily improve overall long-term outcome in elective aneurysm clipping.

Authors:  Tobias Greve; Veit M Stoecklein; Franziska Dorn; Sophia Laskowski; Niklas Thon; Jörg-Christian Tonn; Christian Schichor
Journal:  J Neurosurg       Date:  2019-03-29       Impact factor: 5.115

6.  Intraoperative use of transcranial motor/sensory evoked potential monitoring in the clipping of intracranial aneurysms: evaluation of false-positive and false-negative cases.

Authors:  Jaewoo Chung; Wonhyoung Park; Seok Ho Hong; Jung Cheol Park; Jae Sung Ahn; Byung Duk Kwun; Sang-Ahm Lee; Sung-Hoon Kim; Ji-Ye Jeon
Journal:  J Neurosurg       Date:  2018-03-23       Impact factor: 5.115

7.  Intraoperative monitoring for intracranial aneurysms: the Michigan experience.

Authors:  Kinshuk Sahaya; Aditya S Pandey; Byron G Thompson; Brian R Bush; Daniela N Minecan
Journal:  J Clin Neurophysiol       Date:  2014-12       Impact factor: 2.177

8.  Strategies and Pitfalls of Motor-Evoked Potential Monitoring during Supratentorial Aneurysm Surgery.

Authors:  Yuichi Maruta; Masami Fujii; Hirochika Imoto; Sadahiro Nomura; Nobuhiro Tanaka; Akinori Inamura; Hirokazu Sadahiro; Fumiaki Oka; Hisaharu Goto; Satoshi Shirao; Makoto Ideguchi; Hiroshi Yoneda; Eiichi Suehiro; Hiroyasu Koizumi; Hideyuki Ishihara; Michiyasu Suzuki
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-11-27       Impact factor: 2.136

9.  Intraoperative neurophysiological monitoring of extracranial-intracranial bypass procedures.

Authors:  Julius Dengler; Mario Cabraja; Katharina Faust; Thomas Picht; Theodoros Kombos; Peter Vajkoczy
Journal:  J Neurosurg       Date:  2013-05-10       Impact factor: 5.115

10.  Ischemia changes and tolerance ratio of evoked potential monitoring in intracranial aneurysm surgery.

Authors:  Dezhi Kang; Peisen Yao; Zanyi Wu; Lianghong Yu
Journal:  Clin Neurol Neurosurg       Date:  2012-07-12       Impact factor: 1.876

View more
  1 in total

1.  Clinical Usage of Different Doses of Cis-Atracurium in Intracranial Aneurysm Surgery and Its Effect on Motor-Evoked Potentials.

Authors:  Zhongyuan Qiao; Rong Fan
Journal:  Comput Math Methods Med       Date:  2022-06-28       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.